Oaktree Acquisition Corp. III Life Sciences (OACC) Change in Cash (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences (OACC) reported Change in Cash of -$158035.0 for Q1 2026, down 109.15% on a YoY basis from $1.7 million in Q1 2025, and down 248.92% quarter-over-quarter from $106124.0 in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) Change in Cash (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported Change in Cash for 2 years, with the latest figure at -$158035.0 in Q1 2026.

  • For the quarter ending Q1 2026, Change in Cash fell 109.15% year-over-year to -$158035.0; the trailing twelve-month figure through Mar 2026 stood at -$4553.0 (changed N/A YoY), and the FY2025 full-year result was $77921.0, down 94.26% from the prior year.
  • Change in Cash for Q1 2026 stood at -$158035.0, down from $106124.0 in the prior quarter.
  • The five-year high for Change in Cash was $106124.0 in Q4 2025, with the low at -$158035.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - 378,972.00
2 Berto Acquisition 312.46 Mn 312.46 Mn - -369,667.00
3 Centurion Acquisition 311.65 Mn 311.65 Mn - -72,157.00
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - -32,793.00
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - 165,329.00
6 WEN Acquisition 309.15 Mn 309.15 Mn - -208,889.00
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn - 328,760.00
8 Soulpower Acquisition 264.91 Mn 264.91 Mn - -150,705.00
9 BTC Development 262.16 Mn 262.16 Mn - -537,350.00
10 Oaktree Acquisition Corp. III Life Sciences 57.34 Mn 57.34 Mn - -158,035.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -158,035.00
Dec 31, 2025 106,124.00
Sep 30, 2025 -56,518.00
Jun 30, 2025 103,876.00
Mar 31, 2025 -75,561.00